Evaluation of the antiproliferative, proapoptotic, and antiangiogenic effects of a double-stranded RNA mimic complexed with polycations in an experimental mouse model of leiomyoma

Fertil Steril. 2016 Feb;105(2):529-38. doi: 10.1016/j.fertnstert.2015.10.037. Epub 2015 Nov 23.

Abstract

Objective: To assess the antiproliferative, proapoptotic, and antiangiogenic effects of the double-stranded RNA mimic polyinosine-polycytidylic acid (pIC) complexed with polyethylenimine [pIC(PEI)] in xenografted human leiomyomas.

Design: Heterologous leiomyoma mouse model.

Setting: University-affiliated infertility center.

Animal(s): Ovariectomized and hormone-replaced nude mice (n = 16) who received human leiomyoma fragment transplantation.

Intervention(s): Leiomyoma fragments placed in the peritoneum of 5-week-old nude female mice and treated with the vehicle (n = 8) or 0.6 mg/kg [pIC(PEI)] (n = 8) for 4 weeks.

Main outcome measure(s): The size of the leiomyoma implants, and cellular proliferation (Ki67), vascularization (PECAM), and apoptosis (OH-ends) assessed by quantitative immunohistochemical/immunofluorescent analysis of the recovered implants.

Result(s): No significant differences were observed in the size of the leiomyoma implants between groups. Vascularization and proliferation were significantly decreased, and apoptosis was increased in the [pIC(PEI)]-treated group versus control.

Conclusion(s): We hypothesize that the antiangiogenic and apoptotic effects exerted by [pIC(PEI)] might lead to a decrease in lesion size in this animal model if the compound is administered for longer periods of time. This study provides promising data on [pIC(PEI)] as a potential novel therapeutic agent against human leiomyoma.

Keywords: Angiogenesis; [pIC(PEI)]; apoptosis; leiomyoma; mouse model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Angiogenesis Inhibitors / pharmacology*
  • Animals
  • Apoptosis / drug effects*
  • Cell Proliferation / drug effects*
  • Disease Models, Animal
  • Estrogen Replacement Therapy
  • Female
  • Humans
  • Ki-67 Antigen / metabolism
  • Leiomyoma / blood supply
  • Leiomyoma / drug therapy*
  • Leiomyoma / genetics
  • Leiomyoma / metabolism
  • Leiomyoma / pathology
  • Mice, Nude
  • Middle Aged
  • Neovascularization, Pathologic*
  • Ovariectomy
  • Platelet Endothelial Cell Adhesion Molecule-1 / metabolism
  • Poly I-C / pharmacology*
  • Polyethyleneimine / pharmacology*
  • Time Factors
  • Tumor Burden / drug effects
  • Tumor Cells, Cultured
  • Uterine Neoplasms / blood supply
  • Uterine Neoplasms / drug therapy*
  • Uterine Neoplasms / genetics
  • Uterine Neoplasms / metabolism
  • Uterine Neoplasms / pathology
  • Xenograft Model Antitumor Assays

Substances

  • Angiogenesis Inhibitors
  • Ki-67 Antigen
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Polyethyleneimine
  • Poly I-C